Tirzepatide in Elmhurst, IL, Physician Evaluation, Not a Refill Subscription
Dr. Thomas Caraballo, DO reviews your labs, metabolic history, and health goals before prescribing tirzepatide. Fashioned Health, 105 S York St, Suite 215, Elmhurst, Illinois.
What Is Tirzepatide?
Tirzepatide is a dual GIP/GLP-1 receptor agonist, it activates two separate hormonal pathways that regulate appetite, gastric emptying, and insulin sensitivity simultaneously. This dual mechanism is what distinguishes it from semaglutide, which targets only GLP-1 receptors.
In clinical trials, tirzepatide produced average body weight reductions of 20 to 22% over 72 weeks, the largest reduction of any approved weight loss medication to date. Individual results vary significantly based on starting weight, metabolic health, adherence, and lifestyle factors.
Tirzepatide is the active ingredient in Mounjaro (approved for type 2 diabetes) and Zepbound (approved for chronic weight management in adults with BMI at least 30, or at least 27 with a weight related condition).
Tirzepatide vs. Semaglutide, Which Is Right for You?
Both are GLP-1 class medications. The difference is mechanism and magnitude.
| Factor | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GLP-1 + GIP receptor agonist |
| Average weight reduction (clinical trials) | ~14 to 16% body weight | ~20 to 22% body weight |
| Approved brand names | Ozempic (diabetes), Wegovy (weight) | Mounjaro (diabetes), Zepbound (weight) |
| Administration | Weekly subcutaneous injection | Weekly subcutaneous injection |
| Insulin sensitivity effect | Moderate (via GLP-1) | Stronger (GLP-1 + GIP together) |
| Metabolic syndrome applicability | Strong | Strongest available |
| Side effect profile | GI-dominant (nausea, constipation) | Similar GI profile; may vary by person |
Why Physician Oversight Matters for Tirzepatide
Tirzepatide is a weekly injectable medication with meaningful contraindications, titration requirements, and monitoring needs. Prescribing it through a 5-minute online form skips the clinical context that determines whether the medication is appropriate, which dose to start at, and when to adjust.
At Fashioned Health, tirzepatide prescribing includes:
- Full health history review, prior conditions, medications, surgical history
- Baseline labs, metabolic panel, HbA1c, thyroid, lipids, hormonal markers as indicated
- Contraindication screening (MTC history, MEN 2, pregnancy, pancreatitis history)
- A realistic conversation about expected results, timeline, and lifestyle integration
- Ongoing monitoring, dose titration, side effect management, lab rechecks
This is different from a telehealth prescription subscription that ships medication without knowing your baseline or following you over time.
How Fashioned Health Approaches Tirzepatide Treatment
Fashioned Health vs. Online GLP-1 Platforms
| Fashioned Health | Telehealth GLP-1 Platforms | |
|---|---|---|
| Prescribing physician | Dr. Caraballo, DO, same physician every visit | Rotating physicians or NPs; automated queues |
| Baseline labs required | Yes, before any prescription | Often self-reported or skipped |
| In person evaluation | Yes, Elmhurst clinic | No, video or form only |
| Contraindication screening | Full clinical review | Checkbox intake form |
| Ongoing monitoring | Physician-led follow-up visits and lab rechecks | App check-ins; minimal follow-up |
| Metabolic + hormonal integration | Reviewed together (thyroid, insulin, hormonal) | Weight-only focus |
| Access to physician | Direct, private practice model | Queue-based; delayed responses |
Who Is a Candidate for Tirzepatide?
Adults who may benefit from tirzepatide include those with:
- BMI at least 30, or BMI at least 27 with a weight related condition (type 2 diabetes, hypertension, dyslipidemia, sleep apnea)
- Insulin resistance or metabolic syndrome
- Type 2 diabetes with weight as a contributing factor
- Significant difficulty losing weight despite dietary and lifestyle efforts
- Prior GLP-1 use (semaglutide) with partial response, considered on a case by case basis
Tirzepatide is not appropriate for patients with a personal or family history of medullary thyroid carcinoma, MEN 2, active pancreatitis, or during pregnancy. Dr. Caraballo will review all contraindications at your consultation.
Serving Elmhurst and DuPage County
Fashioned Health is located in Elmhurst at 105 S York St, Suite 215, accessible from I-290 and Route 83, and walkable from the Elmhurst Metra station. Patients come from Elmhurst, Hinsdale, Oak Brook, Downers Grove, Villa Park, Lombard, Wheaton, and across DuPage County.
If you have been relying on a telehealth subscription service or a med spa for GLP-1 medication and want physician led oversight instead, a consultation at Fashioned Health is the appropriate next step.
Related Services at Fashioned Health
- GLP-1 Weight Loss, Elmhurst
- Semaglutide in Elmhurst
- GLP-1 Weight Loss (main service page)
- Hormone Optimization
- Testosterone Therapy, Elmhurst
- Concierge Medicine
- Schedule a Consultation
Frequently Asked Questions, Tirzepatide in Elmhurst, IL
Tirzepatide is a dual GIP and GLP-1 receptor agonist. It targets two hormonal pathways simultaneously, reducing appetite, slowing gastric emptying, and improving insulin sensitivity. Clinical trials showed average body weight reductions of 20 to 22% over 72 weeks.
Semaglutide activates only GLP-1 receptors. Tirzepatide activates both GLP-1 and GIP receptors. The dual mechanism generally produces greater weight loss. Dr. Caraballo reviews your labs and metabolic profile to determine which medication fits your situation.
Yes. Baseline labs are required at Fashioned Health before prescribing tirzepatide, metabolic panel, thyroid screen, HbA1c, lipid panel, and relevant hormonal markers. We do not prescribe without this clinical context.
Yes. Tirzepatide is the active ingredient in both. Mounjaro is FDA approved for type 2 diabetes; Zepbound is FDA approved for chronic weight management. Dr. Caraballo will discuss which formulation and dose is appropriate.
The most common are gastrointestinal: nausea, diarrhea, decreased appetite, constipation. Most patients tolerate tirzepatide well when doses are started low and increased gradually. Dr. Caraballo monitors your response and adjusts titration as needed.
Contraindicated in patients with personal or family history of medullary thyroid carcinoma or MEN 2. Not recommended during pregnancy or breastfeeding. Thyroid screen and health history review are part of every evaluation.
Yes. Dr. Thomas Caraballo, DO prescribes tirzepatide at 105 S York St, STE 215, Elmhurst, IL 60126. This is not a telehealth only service, you meet with the physician and receive ongoing in person monitoring.
Schedule a consultation at fashionedhealth.com/consult/. Dr. Caraballo will review your health history, order baseline labs, and discuss whether tirzepatide or another metabolic approach is the right fit.
Ready to talk to an actual physician about tirzepatide?
Dr. Caraballo reviews your labs and health history before any prescription decision. This is physician led care, not a subscription service.
Schedule a ConsultationFashioned Health | 105 S York St, Suite 215, Elmhurst, IL 60126 | Serving DuPage County and western Chicago suburbs
